Northern Trust Corp Nex Immune, Inc. Transaction History

Northern Trust Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.61 - $4.68 $201,108 - $584,588	-124,912 Reduced 90.79%	12,668 $20,000
Q1 2022 May 13, 2022	SELL	$1.79 - $4.65 $3,674 - $9,546	-2,053 Reduced 1.47%	137,580 $580,000
Q4 2021 Feb 08, 2022	SELL	$4.11 - $15.13 $11,014 - $40,548	-2,680 Reduced 1.88%	139,633 $644,000
Q3 2021 Nov 15, 2021	BUY	$10.32 - $16.9 $757,199 - $1.24 Million	73,372 Added 106.43%	142,313 $2.15 Million
Q2 2021 Aug 13, 2021	SELL	$14.98 - $23.89 $13,931 - $22,217	-930 Reduced 1.33%	68,941 $1.13 Million
Q1 2021 May 12, 2021	BUY	$17.95 - $25.91 $1.25 Million - $1.81 Million	69,871 New	69,871 $1.33 Million

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $5.07M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.